This article breaks down why semaglutide cannot currently be delivered through skin, what the MHRA says about such products, and how to choose safe, evidence-based obesity treatments in the UK
With regard to the utility of GLP-1R agonists in myocardial IRI, the first report by Nikolaidis et al
However, the children's pediatricians confirmed exclusion and inclusion criteria by completing the Pediatrician Form, which also provided details of general health and previous medical history and recommendation for participation in the trial
Still basking in the afterglow of its Wegovy pill launch earlier this year, Novo Nordisk has achieved another victory as it strives to make the most out of its blockbuster GLP-1 drug in an increasingly pressured obesity market
Key RDN Interventions for GLP-1 Success: Protein optimization: Calculating and achieving high-protein targets despite reduced appetite and food aversions Side effect mitigation: Using specific nutritional strategies to reduce nausea, constipation, and reflux Micronutrient adequacy: Preventing deficiencies through strategic food choices and supplementation when needed Muscle preservation: Combining protein timing, resistance training guidance, and leucine-rich meal planning Behavioral skill building: Teaching portion control, mindful eating, and hunger awareness for long-term success The Growing Demand: Career Opportunities for Nutrition Professionals The market for GLP-1 nutrition counseling is expanding faster than the pipeline of trained professionals
wellness Healthspan vs Lifespan: Living Longer vs Living Well Healthspan vs lifespan explained: the difference between how long you live and how long you live well, and why longevity medicine targets healthspan